Keller ET - Search Results

1

Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer.

Fu Z, Kitagawa Y, Shen R, Shah R, Mehra R, Rhodes D, Keller PJ, Mizokami A, Dunn R, Chinnaiyan AM, Yao Z, Keller ET. Fu Z, et al. Among authors: keller pj, keller et. Prostate. 2006 Feb 15;66(3):248-56. doi: 10.1002/pros.20319. Prostate. 2006. PMID: 16175585 Free article.

2

Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line.

Mizokami A, Gotoh A, Yamada H, Keller ET, Matsumoto T. Mizokami A, et al. Among authors: keller et. J Urol. 2000 Sep;164(3 Pt 1):800-5. doi: 10.1097/00005392-200009010-00053. J Urol. 2000. PMID: 10953159

3

Chronic alcohol ingestion induces osteoclastogenesis and bone loss through IL-6 in mice.

Dai J, Lin D, Zhang J, Habib P, Smith P, Murtha J, Fu Z, Yao Z, Qi Y, Keller ET. Dai J, et al. Among authors: keller et. J Clin Invest. 2000 Oct;106(7):887-95. doi: 10.1172/JCI10483. J Clin Invest. 2000. PMID: 11018077 Free PMC article.

4

Ethanol activates NFkappaB DNA binding and p56lck protein tyrosine kinase in human osteoblast-like cells.

Yao Z, Zhang J, Dai J, Keller ET. Yao Z, et al. Among authors: keller et. Bone. 2001 Feb;28(2):167-73. doi: 10.1016/s8756-3282(00)00425-7. Bone. 2001. PMID: 11182374

5

Long-term exposure of tumor necrosis factor alpha causes hypersensitivity to androgen and anti-androgen withdrawal phenomenon in LNCaP prostate cancer cells.

Harada S, Keller ET, Fujimoto N, Koshida K, Namiki M, Matsumoto T, Mizokami A. Harada S, et al. Among authors: keller et. Prostate. 2001 Mar 1;46(4):319-26. doi: 10.1002/1097-0045(20010301)46:4<319::aid-pros1039>3.0.co;2-c. Prostate. 2001. PMID: 11241555

6

The impact of chronic estrogen deprivation on immunologic parameters in the ovariectomized rhesus monkey (Macaca mulatta) model of menopause.

Keller ET, Zhang J, Yao Z, Qi Y. Keller ET, et al. J Reprod Immunol. 2001 Apr;50(1):41-55. doi: 10.1016/s0165-0378(00)00087-5. J Reprod Immunol. 2001. PMID: 11254940

7

Interleukin-6 and prostate cancer progression.

Smith PC, Hobisch A, Lin DL, Culig Z, Keller ET. Smith PC, et al. Among authors: keller et. Cytokine Growth Factor Rev. 2001 Mar;12(1):33-40. doi: 10.1016/s1359-6101(00)00021-6. Cytokine Growth Factor Rev. 2001. PMID: 11312117 Review.

8

Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro.

Lin DL, Tarnowski CP, Zhang J, Dai J, Rohn E, Patel AH, Morris MD, Keller ET. Lin DL, et al. Among authors: keller et. Prostate. 2001 May 15;47(3):212-21. doi: 10.1002/pros.1065. Prostate. 2001. PMID: 11351351 Free article.

9

Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone.

Zhang J, Dai J, Qi Y, Lin DL, Smith P, Strayhorn C, Mizokami A, Fu Z, Westman J, Keller ET. Zhang J, et al. Among authors: keller et. J Clin Invest. 2001 May;107(10):1235-44. doi: 10.1172/JCI11685. J Clin Invest. 2001. PMID: 11375413 Free PMC article.

10

Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice.

Smith PC, Keller ET. Smith PC, et al. Among authors: keller et. Prostate. 2001 Jun 15;48(1):47-53. doi: 10.1002/pros.1080. Prostate. 2001. PMID: 11391686 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters